(Q43485762)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22782690%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22782690%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22782690%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Paul A. Scuffham

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22782690%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Megan K Young

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22782690%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

S K Ng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22782690%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Shu-Kay Ng

2

1 reference

23 November 2017

publication date

11 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22782690%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

number of pages

8

1 reference

inferred from page(s)

published in

Quality of Life Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22782690%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22782690%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22782690%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1065-1072

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22782690%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11136-012-0231-6

7 February 2020

exact match

0 references

cites work

Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Quality of life in Parkinson's disease: the relative importance of the symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Self-management rehabilitation and health-related quality of life in Parkinson's disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Impact of pre-morbid depression on health-related quality of life in non-demented Parkinson's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Depressive symptoms and perception of quality of life in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Short-term cost and health consequences of duodenal levodopa infusion in advanced Parkinson's disease in Sweden: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Treatment of advanced Parkinson's disease in the United States: a cost-utility model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: an economic Markov model evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Coping processes and health-related quality of life in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

The Parkinson's Disease Questionnaire (PDQ-39): evidence for a method of imputing missing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Assessing proportionality in the proportional odds model for ordinal logistic regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Preference-Based EQ-5D index scores for chronic conditions in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0231-6

Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22782690

12 December 2020

inferred from PubMed ID database lookup

Quality of life in patients with Parkinson's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22782690

12 December 2020

inferred from PubMed ID database lookup

Modeling valuations for EuroQol health states

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22782690

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11136-012-0231-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22782690%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 February 2020

1037672713

0 references

Fatcat ID

release_73jx7eoqm5hb7d25ojgwpjarnm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/73jx7eoqm5hb7d25ojgwpjarnm

24 November 2022

mapped directly with Wikidata item

1 reference